Annexon Biosciences's total assets for Q1 2025 were $303.03M, a decrease of -13.44% from the previous quarter. ANNX total liabilities were $59.24M for the fiscal quarter, a 3.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.